DGFT places Remdesivir injection export policy under the restricted Category.
The export of Remdesivir injections and APIs against the Advance Authorization shall no longer require a separate export authorisation or permission as, under the revised policy, the drug has been moved from ‘prohibited’ to ‘restricted’ category.
ESI Provides covid-19 relief to the dependants of the insured person.
The insured persons, who fulfill the eligibility conditions, and have died due to Covid-19, their dependants will be entitled to receive monthly payment which will be 90 per cent of average daily wages of the insured person during their life.
Government of Tamil Nadu waives penalty for late registration of birth and death certificates.
As per the Registration of Birth and Death (RBD) Act, 1969, a Normal period of 21 days (from the date of occurrence) has been prescribed for reporting the birth, death and still birth event and in case of any delay in registering the birth or death a penalty of Rs.100 to 500 is charged.
Mohfw issues revised Guidelines for implementation of National COVID Vaccination Program
The price of vaccine doses for private hospitals would be declared by each vaccine manufacturer, and any subsequent changes would be notified in advance. The private hospitals may charge up to a maximum of Rupees 150 per dose as service charges.
Mohfw Issues advisory for rational use of Remdesivir for COVID-19 Treatment.
The Remdesivir is to be used only in select moderate/ severe hospitalised Covid – 19 patients on supplemental oxygen as it is a reserve drug approved under Emergency Use Authorization only based on limited scientific evidence globally and It is not indicated in mild Covid – 19 patients who are in home care/ Covid Care Centres.
Mohfw Issues SOP for Administration of Second Dose of Covisheld for people traveling abroad.
The States/UT governments shall designate a competent authority in each District for according permission for such administration of second dose of Covishield.
NPPA caps retail price of 12 formulations under DPCO-2013.
The retail price is applicable only to the individual manufacturer / marketer, subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority.
The Ministry of Chemicals and Fertilizers caps Trade Margin on Oxygen Concentrators.
Every retailer, dealer, hospital and institution to display the price list as furnished by the manufacturer, on a conspicuous part of the business premises in a manner so as to be easily accessible to any person wishing to consult the same.
The Ministry of Chemical issues Operational guidelines for Production Linked Incentive Scheme of Pharmaceuticals.
The products covered under the scheme are formulations, biopharmaceuticals, active pharmaceutical ingredients, key starting material, drug intermediates, in-vitro diagnostic medical devices, etc.
MoHFW issues Guidance on Diagnosis and Management of Diabetes at COVID-19 Patient Management facility.
The guidance provides a broad overview on the diagnosis and management of hyperglycemia at COVID care facilities and should be useful to a wide range of healthcare personnel involved in care of patients with COVID-19.
